The estimated Net Worth of Joaquin Duato is at least $73.5 Million dollars as of 13 February 2024. Mr. Duato owns over 3,470 units of Johnson & Johnson stock worth over $60,127,819 and over the last 8 years he sold JNJ stock worth over $0. In addition, he makes $13,419,300 as Vice Chairman - Executive Committee at Johnson & Johnson.
Sign up
Mr. Duato JNJ stock SEC Form 4 insiders trading
Joaquin has made over 19 trades of the Johnson & Johnson stock since 2017, according to the Form 4 filled with the SEC. Most recently he exercised 3,470 units of JNJ stock worth $571,925 on 13 February 2024.
The largest trade he's ever made was exercising 148,538 units of Johnson & Johnson stock on 17 January 2023 worth over $10,774,947. On average, Joaquin trades about 31,041 units every 102 days since 2017. As of 13 February 2024 he still owns at least 364,809 units of Johnson & Johnson stock.
You can see the complete history of Mr. Duato stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Joaquin Duato biography
Joaquin Boix Duato serves as Vice Chairman - Executive Committee of the Company. He joined the Company in 1989 with Janssen-Farmaceutica S.A. (Spain), a subsidiary of the Company, and held executive positions of increasing responsibility in the Pharmaceutical sector. In 2009, he was named Company Group Chairman, Pharmaceuticals, and in 2011, he was named Worldwide Chairman, Pharmaceuticals. In 2016, Mr. Duato became a member of the Executive Committee and was named Executive Vice President, Worldwide Chairman, Pharmaceuticals. In July 2018, Mr. Duato was promoted to Vice Chairman of the Executive Committee, with responsibility for the company's Pharmaceutical and Consumer sectors, supply chain, information technology, global services and the Health & Wellness groups.
What is the salary of Joaquin Duato?
As the Vice Chairman - Executive Committee of Johnson & Johnson, the total compensation of Joaquin Duato at Johnson & Johnson is $13,419,300. There are 2 executives at Johnson & Johnson getting paid more, with Alex Gorsky having the highest compensation of $25,365,800.
How old is Joaquin Duato?
Joaquin Duato is 57, he's been the Vice Chairman - Executive Committee of Johnson & Johnson since 2018. There are 19 older and 11 younger executives at Johnson & Johnson. The oldest executive at Johnson & Johnson is Ronald Williams, 70, who is the Independent Director.
What's Joaquin Duato's mailing address?
Joaquin's mailing address filed with the SEC is ONE JOHNSON & JOHNSON PLAZA, , NEW BRUNSWICK, NJ, 08933.
Insiders trading at Johnson & Johnson
Over the last 22 years, insiders at Johnson & Johnson have traded over $59,929,946 worth of Johnson & Johnson stock and bought 21,998 units worth $2,578,685 . The most active insiders traders include Hubert Joly, Anne M Mulcahy, and Alex Gorsky. On average, Johnson & Johnson executives and independent directors trade stock every 21 days with the average trade being worth of $4,572,436. The most recent stock trade was executed by Robert J Decker on 30 August 2024, trading 5,635 units of JNJ stock currently worth $563,838.
What does Johnson & Johnson do?
Johnson & Johnson is an American multinational corporation founded in 1886 that develops medical devices, pharmaceuticals, and consumer packaged goods.
What does Johnson & Johnson's logo look like?
Complete history of Mr. Duato stock trades at Hess and Johnson & Johnson
Johnson & Johnson executives and stock owners
Johnson & Johnson executives and other stock owners filed with the SEC include:
-
Alex Gorsky,
Chairman of the Board, Chief Executive Officer -
Paulus Stoffels,
Vice Chairman- Executive Committee, Chief Scientific Officer -
Joaquin Duato,
Vice Chairman - Executive Committee -
Joseph Wolk,
Chief Financial Officer, Executive Vice President -
Jennifer Taubert,
Executive Vice President - Worldwide Chairman, Pharmaceuticals -
Michael Ullmann,
Executive Vice President, General Counsel -
Alex Gorsky,
Exec. Chairman -
Peter Fasolo,
Chief Human Resource Officer, Executive Vice President -
Dr. Paulus A. Stoffels M.D., Ph.D.,
Chief Scientific Officer -
Joaquin Duato,
CEO & Director -
Joseph J. Wolk CPA,
Exec. VP & CFO -
Joseph J. Wolk C.P.A.,
Exec. VP & CFO -
Jennifer L. Taubert,
Exec. VP & Worldwide Chairman of Pharmaceuticals -
Anne Mulcahy,
Lead Independent Director -
Charles Prince,
Independent Director -
Mary Beckerle,
Independent Director -
Ronald Williams,
Independent Director -
D. Scott Davis,
Independent Director -
A. Eugene Washington,
Independent Director -
Jennifer Doudna,
Independent Director -
Mark McClellan,
Independent Director -
Ian Davis,
Independent Director -
Marillyn Hewson,
Independent Director -
Mark Weinberger,
Independent Director -
Hubert Joly,
Independent Director -
Christopher DelOrefice,
Vice President, Investor Relations -
Kathryn Wengel,
Executive Vice President, Chief Global Supply Chain Officer -
Michael Sneed,
Executive Vice President - Global Corporate Affairs and Chief Communication Officer -
Thibaut Mongon,
Executive Vice President, Worldwide Chairman, Consumer -
Ashley McEvoy,
Executive Vice President - Worldwide Chairman, Medical Devices -
Dr. Guy J. Lebeau M.D.,
Group Chairman of MD&D Bus. - EMEA -
Dr. Peter M. Fasolo Ph.D.,
Exec. VP & Chief HR Officer -
Michael H. Ullmann,
Exec. VP & Gen. Counsel -
Jessica Moore,
VP of Investor Relations -
Ashley Watson,
Chief Compliance Officer -
James Swanson,
Exec. VP & Global CIO -
Robert J. Decker Jr.,
Controller & Chief Accounting Officer -
James Cullen,
Director -
Stephen J Cosgrove,
-
Leo F Mullin,
Director -
Michael M E Johns,
Director -
Robert J Decker,
VP Corporate Controller -
Elizabeth Forminard,
Executive VP, General Counsel -
Ronald A Kapusta,
Controller, CAO -
Susan L Lindquist,
Director -
Gary J Pruden,
Exec VP, WW Chair, Med Devices -
William D Perez,
Director -
Jorge S. Mesquita,
Exec VP, WW Chair, Consumer -
Dominic J Caruso,
Chief Financial Officer -
Timothy Schmid,
EVP, WW Chair, MedTech -
Mary Sue Coleman,
Director -
David Satcher,
Director -
William C Weldon,
Chairman/CEO -
Arnold G Langbo,
Director -
Russell C Deyo,
Vice President, Administration -
Kaye I Foster Cheek,
VP, Human Resources -
Colleen A Goggins,
Member, Executive Committee -
Sherilyn S Mc Coy,
Member, Executive Committee -
Donald M Jr. Casey,
Member, Executive Committee -
Nicholas J Valeriani,
Vice President,Human Resources -
Christine A Poon,
Executive Committee Member -
Joseph C Scodari,
Executive Committee Member -
Steven Reinemund,
Director -
Ann Dibble Jordan,
Director -
Robert J Darretta,
Member, Executive Committee -
Per A Peterson,
Executive Committee Member -
Michael J Dormer,
Member, Executive Committee -
Joann Heffernan Heisen,
Member, Executive Committee -
Gerard N Burrow,
Director -
Henry B Schacht,
Director -
M Judah Folkman,
Director -
Roger S Fine,
Vice President General Counsel -
James T Lenehan,
Vice Chairman -
Brian D Perkins,
Executive Committee Member -
Robert N Wilson,
-
Nadja West,
Director -
Vanessa Broadhurst,
EVP, Global Corp Affairs -
Mathai Mammen,
EVP, Pharm, R&D -
William Hait,
EVP, Chief EI and Med Officer -
Darius Adamczyk,
Director -
James D. Swanson,
EVP, CIO -
John C Reed,
EVP, Innovative Medicine, R&D -
Paula A Johnson,
Director -
Eugene A. Woods,
Director